FDA Commissioner Henney's Office Structure To Be Proposed By Jan. 8
This article was originally published in The Rose Sheet
Executive Summary
A structural plan for the FDA commissioner's office is expected to be proposed to newly elected Commissioner Jane Henney, MD, by Jan. 8, FDA Associate Commissioner for Strategic Management Linda Suydam said at the Food & Drug Law Institute's annual meeting in Washington, D.C. Dec. 16.